GaryYYangMD

PubMed

• Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions
  Alex Coffman, Daniel C Sufficool, Joseph I. Kang, Chung-Tsen Hsueh, Sasha Swenson, Patrick Q McGee, Gayathri Nagaraj, Baldev Patyal, Mark E. Reeves, Jerry D. Slater, G...> ;Journal of gastrointestinal oncology. 2021 Aug 1
• Treatment Factors Associated With Overall Survival in Retroperitoneal Sarcoma: An Institutional Review.
  Mei L Kwong, Becky Lee, Karissa Kunihira, Brian Sutjiadi, Mark E. Reeves, Matthew J. Selleck, Gary Y. Yang, Naveenraj L. Solomon> ;American Surgeon. 2020 Oct 30
• 8 citations
  A phase I trial of Proton stereotactic body radiation therapy for liver metastases
  Joseph I. Kang, Daniel C. Sufficool, Chung-Tsen Hsueh, Andrew J. Wroe, Baldev Patyal, Mark E. Reeves, Jerry D. Slater, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2018 Sep 17
• 6 citations
  Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer.
  Brice Jabo, Matthew J. Selleck, John Morgan, Sharon S. Lum, Khaled Bahjri, Mayada Aljehani, Carlos A. Garberoglio, Mark E. Reeves, Jukes P. Namm, Naveenraj L. Solomon,...> ;Journal of gastrointestinal oncology. 2018 Jun 13
• 3 citations
  Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors.
  Matthew L Knecht, N Wang, April Vassantachart, Rachel Mifflin, Jerry D. Slater, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2017 Nov 1
• 10 citations
  Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer
  Inhwan Yeo, P Nookala, Ian Gordon, Reinhard W. Schulte, Stanley Barnes, A Ghebremedhin, N Wang, Gary Y. Yang, Ted C. Ling, David A. Bush, Jerry D. Slater, Baldev Patyal> ;Radiation Oncology. 2015 Oct 24
• 9 citations
  Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848.
  Ted C. Ling, Jerry M. Slater, Rachel Mifflin, P Nookala, Roger Grove, Anh M. Ly, Baldev Patyal, Jerry D. Slater, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2015 Apr 1
• 36 citations
  Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Eso...
  Ted C. Ling, Jerry M. Slater, P Nookala, Rachel Mifflin, Roger Grove, Anh M. Ly, Baldev Patyal, Jerry D. Slater, Gary Y. Yang> ;Cancers. 2014 Dec 5
• 5 citations
  Palliative radiation therapy for primary gastric melanoma.
  Jason M. Slater, Ted C. Ling, Jerry D. Slater, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2014 Jul 1
• 4 citations
  Surgical and radiation therapy management of recurrent anal melanoma.
  Ted C. Ling, Jason M. Slater, Maheswari Senthil, Kevork Kazanjian, Frank Howard, Carlos A. Garberoglio, Jerry D. Slater, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2014 Jan 13
• 26 citations
  Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer
  Gary Y. Yang, N.K. Malik, Rameela Chandrasekhar, Wen Wee Ma, Leayn Flaherty, Renuka Iyer, Boris W. Kuvshinoff, John F. Gibbs, Gregory E. Wilding, Graham W. Warren, Kil...> ;Journal of gastrointestinal oncology. 2013 Sep 25
• 20 citations
  Erlotinib and radiation therapy for elderly patients with esophageal cancer - Clinical and correlative results from a prospective multicenter phase 2 trial
  Renuka Iyer, Ravi Chhatrala, Tracey Shefter, Gary Y. Yang, Usha Malhotra, Wei Tan, Charles LeVea, Melissa Robins, Nikhil I. Khushalani> ;Oncology. 2013 Jan 1
• Proton therapy for hepatocellular carcinoma.
  Ling, T. C.,Kang, J. I.,Bush, D. A.,Slater, J. D.,Yang, G. Y.> ;Chin J Cancer Res. 2012 Dec
• 24 citations
  In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer
  Chunqing Guo, Huanfa Yi, Xiaofei Yu, Daming Zuo, Jie Qian, Gary Y. Yang, Barbara A. Foster, John R. Subjeck, Xiaolei Sun, Ross B. Mikkelsen, Paul B. Fisher, Xiang-Yang...> ;Molecular Cancer Therapeutics. 2012 Nov 1
• 45 citations
  Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.
  N.K. Malik, Kilian Salerno May, Rameela Chandrasekhar, Wen Wee, Leayn Flaherty, Renuka Iyer, John F. Gibbs, Boris W. Kuvshinoff, Gregory E. Wilding, Graham W. Warren, ...> ;Journal of gastrointestinal oncology. 2012 Feb 11
• 4 citations
  Proton therapy for esophageal cancer
  Joseph I. Kang, Jerry D. Slater, Gary Y. Yang> ;Thoracic Cancer. 2012 Feb 1
• 1 citations
  The Role of Radiation in the Perioperative Treatment of Esophagogastric Cancer
  Kilian Salerno May, Gary Y. Yang, Nikhil I. Khushalani> ;Current Treatment Options in Oncology. 2011 Jan 26
• 15 citations
  Does circular stapled esophagogastric anastomotic size affect the incidence of postoperative strictures
  Sai Yendamuri, Lyndsay Gutierrez, Adeleke Oni, Terry Mashtare, Nikhil I. Khushalani, Gary Y. Yang, Hector R. Nava, Todd L. Demmy, Chukwumere Nwogu> ;Journal of Surgical Research. 2011 Jan 1
• 16 citations
  Renal Atrophy Secondary to Chemoradiotherapy of Abdominal Malignancies
  Gary Y. Yang, Kilian Salerno May, Renuka Iyer, Rameela Chandrasekhar, Gregory E. Wilding, Susan A. McCloskey, Nikhil I. Khushalani, Saikrishna S. Yendamuri, John F. Gi...> ;International Journal of Radiation Oncology Biology Physics. 2010 Oct 1
• Message from the Editor-in-Chief.
  Yang, G. Y.> ;J Gastrointest Oncol. 2010 Sep 01
• 5 citations
  Aorto-esophageal fistula: a rare fatal case caused by esophageal malignancy
  Richard Y. Lee, Leayn Flaherty, Nikhil I. Khushalani, Kazunori Kanehira, Chukwumere Nwogu, Saikrishna S. Yendamuri, Hector R. Nava, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2010 Aug 28
• 23 citations
  FDG PET imaging in the staging and management of gastric cancer
  Shane Hopkins, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2011 Mar 1
• 7 citations
  Management of stage II/III rectal cancer
  Timothy D. Wagner, Marwan Fakih, Gary Y. Yang> ;Journal of gastrointestinal oncology. 2010 Aug 22
• 3 citations
  Association of Technetium99m MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal mal...
  Kilian Salerno May, Gary Y. Yang, Nikhil I. Khushalani, Rameela Chandrasekhar, Gregory E. Wilding, Leayn Flaherty, Harish K. Malhotra, Richard Russo, John C Warner, J....> ;Journal of gastrointestinal oncology. 2010 Aug 17
• 5 citations
  Intensity modulated radiation therapy in the treatment of esophageal cancer.
  J. Yap, Harish K. Malhotra, Gary Y. Yang> ;Thoracic Cancer. 2010 Jul 1
• Join now to see all

Journal Articles

• Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors  
  Knecht M, Knecht ML, Wang N, Vassantachart A, Mifflin R, Slater JD, Yang GY, J Gastrointest Oncol, 1/1/2017
• Protons offer reduced tissue exposure for patients receiving radiation therapy for pancreatic cancer  
  Slater JM, Ling TC, Nookala P, Mifflin R, Grove R, Ly AM, Patyal B, Slater JD,Yang GY, Int J Particle Ther, 1/1/2014
• Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer  
  Yang GY, Malik N, Chandrasekhar R, , Ma WW, Watroba N, Flaherty L, Iyer R, Kuvshinoff BW, Gibbs JF, Wilding GE, Salerno May K, Journal of Gastroint Oncol, 1/1/2013
• Erlotinib and radiation therapy for elderly patients with esophageal cancer - clinical and correlative results from a prospective multicenter phase 2 trial  
  Renuka I, Chhatrala R, Shefter T, Yang G, Malhotra U, Wei T, LeVea C, Robins M,Khushalani N, Oncology, 1/1/2013
• Treatment of locally advanced unresectable pancreatic cancer: A 10-year experience  
  Malik NK, Salerno May K, Groman A, Patil1 S, Gibbs J, Kuvshinoff B, Ma W, Iyer R, Warren G, Yang GY, Journal of Gastroint Oncol, 1/1/2012
• Proton therapy for gastrointestinal cancer  
  Ling TC, Kang JI, Slater JD, Yang GY, Translational Cancer Research, 1/1/2012
• Proton therapy for hepatocellular carcinoma  
  Ling TC, Kang JI, Bush DA, Slater JD, Yang GY, Chinese Journal of Cancer Research, 1/1/2012
• In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer  
  Guo CQ, Yi H, Yu X, Zuo D, Qian J, Yang G, Foster BA, Subjeck JR, Sun X, Mikkelson RB, Fisher PB, Wang XY, Molecular Cancer Therapeutics, 1/1/2012
• Stereotactic Body Proton Therapy for Liver Metastases  
  Kang JI, Ling TC, Slater JD, Yang GY, Translational Cancer Research, 1/1/2012
• PET as predictor of rectal cancer response during or following neoadjuvant chemoradiation  
  Hopkins S, Fakih M, Yang GY, World J Gastrointest Oncology, 1/1/2011
• FDG PET imaging in the staging and management of gastric cancer  
  Hopkins S, Yang GY, Journal of Gastroint Oncol, 1/1/2011
• The role of radiation in the peri-operative treatment of gastroesophageal cancer  
  Salerno May K, Yang GY, Khushalani NI, Current Treatment Options in Oncology, 1/1/2011
• Does circular stapled esophagogastric anastomotic size affect the incidence of post-operative strictures?  
  Yendamuri S, Gutierrez L, Oni A, Mashtare T, Khushalani N, Yang G, Nava H, Demmy T, Nwogu C, Journal of Surgical Research, 1/1/2011
• Clinical T2N0M0 carcinoma of thoracic esophagus  
  Wagner TD, Khushalani NI, Yang GY, Journal of Thoracic Disease, 1/1/2010
• The role of Pemetrexed in concurrent chemoradiotherapy for non-small cell lung cancer  
  Wagner TD, Yang GY, Current Drug Target, 1/1/2010
• Management of anal cancer in 2010 Part 1: Overview, screening, and diagnosis  
  Abbas A, Yang G, Fakih M, Oncology, 1/1/2010
• Management of anal cancer in 2010 Part 2:Current treatment standards and futuredirections  
  Abbas A, Yang G, Fakih M, Oncology, 1/1/2010
• Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal c...  
  Zheng J, Wang G, Yang GY, Wang D, Luo X, Chen C, Zhang Z, Li Q, Xu W, Li Z, Wang D, Japanese Journal of Clinical Oncology, 1/1/2010
• Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies following chemoradiation to the abd...  
  Salerno May K, Khushalani NI, Chandrasekhar R, Wilding GE, Iyer RV, Ma WW, Flaherty L, Russo RC, Fakih M, Kuvshinoff BW, Gibbs JF, Javle MM, Yang GY, Int J Radiat Oncol Biol Phys, 1/1/2010
• Renal atrophy secondary to chemoradiation treatment for abdominal malignancies  
  Yang GY, Salerno May K, Iyer RV, Chandrasekhar R, Wilding GE, McCloskey SA, Khushalani NI, Yendamuri SS, Gibbs JF, Fakih M, Thomas CR Jr., Int J Radiat Oncol Biol Phys, 1/1/2010
• Association of technetium99m MAG-3 renal scintigraphy with change in creatinine clearancefollowing chemoradiation to the abdomen in patients with gastrointestinal mali...  
  Salerno May K, Yang GY, Khushalani NI, Chandrasekhar R, Wilding GE, Flaherty L, Russo RC, Warner JC, Yap JC, Iyer RV, Nwogu CE, Yendamuri SS, Nava HR, Lamonica D, Thom..., J Gastroint Oncol, 1/1/2010
• Intensity modulated radiation therapy in the treatment of esophageal cancer  
  Yap J, Malhotra H, Yang GY, Thoracic Cancer, 1/1/2010
• Message from the Editor-in-Chief  
  Yang GY, Journal of Gastroint Oncol, 1/1/2010
• Aorto-esophageal fistula: a rare fatal case caused by esophageal malignancy  
  Lee RY, Flaherty L, Khushalani NI, Kanehira K, Nwogu C, Yendamuri S, Nava HR, Yang GY, Journal of Gastroint Oncol, 1/1/2010
• Management of stage II/III rectal cancer  
  Wagner TD, Fakih M, Yang GY, J Gastrointest Oncol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Radiation Therapy for Liver Tumors: Fundamentals and Clinical Practice 
  Chapter: Particle Radiation Therapy for Liver Tumors: Simulation, Planning, and Other Practical Issues 
  Knecht M, Wroe A, Yang GEdition 1st,2017
• Gastrointestinal Malignancies: New Innovative Diagnostics and Treatment 
  Chapter: Proton Therapy: A New Dawn for Gastrointestinal Cancer Treatment 
  Yang GY, Landry JWorld Scientific Publishing Co.2015
• Particle Beam Therapy: Contemporary trends and Reviews 
  Chapter: Charged particle beam therapy: a new dawn for cancer treatment. 
  Giap H, Chuang EY, Yang GYEditors: AME Groups.2014
• Esophageal Tumors: Principles & Practice 
  Wagner TD, Javle M, Yang GYDemos Medical Publishing, Inc.2009
• Chemoradiation in Cancer Therapy 
  Chapter: The Role of Gemcitabine in Combined Modality Therapy 
  Landry JC, Blackstock W, Yang GY, Choy HHumana Press Inc.2003
• Join now to see all

Abstracts/Posters

• Proton SBRT for liver metastases- results of 5-year experience for 80 hepatic lesions based on NRG-BR001.
  Sufficool DC, McGee P, Swenson S, Hsueh C, Nagaraj G, Reeves ME, Slater JD, Yang GY, ASTRO (American Society for Radiation Oncology), 1/1/2018
• Is proton SBRT an attractive option for liver metastases?
  Sufficool DC, McGee P, Slater JD, Yang GY, PTCOG (Particle Therapy Co-Operative Group), 1/1/2018
• A Phase I trial of stereotactic body proton therapy (SBPT) for liver metastases.
  Kang JI, Grove R, Hsueh C, Wroe AJ, Patyal B, Reeves ME, Slater JD, Yang GY, ASTRO (American Society for Radiation Oncology), 1/1/2016
• 4D CT proton treatment planning for pancreatic tumors.
  Knecht M, Wang N, Vassantachart A, Mifflin R, Slater JD, Yang GY, ASTRO (American Society for Radiation Oncology), 1/1/2016
• Protons offer reduced normal-tissue exposure for patients receiving stereotactic body radiation therapy (SBRT) for liver tumors: A comparative study based on RTOG 1112.
  Knecht M, Gordon I, Leeds S, Grove R, Ly A, Patyal B, Slater JD, Yang GY, International Society of Gastrointestinal Oncology (ISGIO), 1/1/2015
• Protons offer reduced cardiac exposure for patients receiving radiotherapy for distal and esophagogastric junction cancer.
  Ling TC, Slater JM, Mifflin R, Nookala P, Grove R, Ly AM, Patyal B, Slater JD, Yang GY, GI Cancers Symposium, 1/1/2014
• A treatment planning evaluation of protons versus IMRT in pancreatic cancer: A comparative study.
  Slater JM, Ling TC, Nookala P, Mifflin R, Grove R, Ly AM, Patyal B, Slater JD, Yang GY, GI Cancers Symposium, 1/1/2014
• Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848.
  Ling TC, Slater JM, Mifflin R, Nookala P, Grove R, Ly AM, Patyal B, Slater JD, Yang GY, ASTRO (American Society for Radiation Oncology), 1/1/2014
• Protons offer reduced cardiopulmonary exposure for patients receiving radiation therapy for esophageal cancer.
  Ling TC, Slater JM, Nookala P, Mifflin R, Grove R, Ly AM, Patyal B, Slater JD, Yang GY, ASTRO (American Society for Radiation Oncology), 1/1/2014
• Proton liver radiotherapy: treatment planning comparison between deep inspiration breath-hold and respiratory gating techniques.
  Wang N, Patyal B, Kang J, Slater J, Yang G, Bush D, Proton Therapy Cooperative Group (PTCOG), 1/1/2013
• Comparative proton and IMRT planning study for prostate cancer with biological tumor volume.
  Yeo I, Nookala P, Gordon I, Schulte R, Patyal B, Yang G, Ling T, Bush D, Slater J, Proton Therapy Cooperative Group (PTCOG), 1/1/2013
• A dosimetriccomparison of hepatocellular carcinoma treated by protons and photons.
  Ling T, Barnes S, Yang G, Yeo I, Grove R, Slater JD, Bush D, ASTRO (American Society for Radiation Oncology), 1/1/2013
• Protons offer reduced normal-tissue exposure for patients receiving radiotherapy for pancreatic head cancer.
  Ling TC, Slater JM, Nookala P, Mifflin R, Grove R, Ly AM, Patyal B, Slater JD,Yang GY, ISGIO (International Society of Gastrointestinal Oncology), 1/1/2013
• Adoption of pelvic radiation therapy for stage II and III rectal cancer in California: A population based study from 1994-2008.
  Kazanjian K, Cho M, Morgan J, Roos M, Senthil M, Yang G, Lum S, Wong J, Pacific Coast Surgical Association Meeting, 1/1/2012
• A comparison of IMRT and 3D CRT in the treatment planning of patients with distal esophageal cancer.
  Patil S, Malik N, May K , Hackett R, Hales L, Groman A, Yang G, Warren GW, GI Cancer Symposium, 1/1/2011
• Phase II multicenter study of erlotinib with radiation therapy for elderly patients with esophageal carcinoma: Final report.
  Iyer RV, Yang G, Schefter TE, Tan W, Nava HR, Levea C, Litwin A, Robins M, Khushalani NI, GI Cancer Symposium, 1/1/2011
• Outcomes of esophageal carcinoma patients treated with trimodality therapy: a single institution experience.
  Malik N, Warren G, Khushalani N, Yendamuri S, Patil S, Zeeck K, Papsidero T, Nava H, Yang G, May K, American Radium Society's 93rd Annual Meeting, 1/1/2011
• Response-based outcomes in patients with esophageal cancer treated with primarily non-cisplatin and 5-fluorouracil-based trimodality therapy.
  Malik NK, Warren GW, Yang G, Zeeck K, Papsidero T, Patil S, Khushalani NI, Sher T, Yendamuri SS, Nava HR, Salerno May K, ASCO (American Society of Clinical Oncology), 1/1/2011
• The effect of smoking history on response and survival outcomes patients with in esophageal cancer treated with neoadjuvant concurrent chemoradiotherapy followed by su...
  Salerno May K, Malik NK, Yang G, Patil S, Flaherty L, Khushalani NI, Sher T, Yendamuri SS, Nava HR, Warren GW, ASCO (American Society of Clinical Oncology), 1/1/2011
• A comparison of VMAT, IMRT, and 3DCRT in the treatment planning of patients with distal esophageal cancer.
  Patil SS, May KS, Hackett RA, Hales LD, VanBenthuysen LD, Malik NK, Schmitt JD, Yang GY, Warren GW, ASTRO (American Society for Radiation Oncology), 1/1/2011
• Outcomes and tolerability of treatment for locally advanced pancreatic cancer patients 65 years or older.
  Malik NK, Salerno May K, Groman A, Patil1 S, Gibbs J, Kuvshinoff B, Ma W, Iyer R, Warren G, Yang G, ASTRO (American Society for Radiation Oncology), 1/1/2011
• Outcomes in patients 65 years or older treated with trimodality therapy for esophageal carcinoma.
  Malik NK, Patil1 S, Groman A, Nava H, Yendamuri S, Nurkin S, Sher T, Warren G, Yang G,May K, ASTRO (American Society for Radiation Oncology), 1/1/2011
• Erlotinib and radiation therapy for elderly patients with esophageal cancer: Clinical and correlative results from a prospective multicenter phase II trial.
  Chhatrala R, Khushalani N, Yang G, Shefter T, Tan W, Iyer R, International Society of Gastrointestinal Oncology (ISGIO) Gastrointestinal Oncology Conference, 1/1/2011
• Change in renal function secondary to chemoradiotherapy for pancreatic cancer.
  Salerno May K, Chandrasekhar R, Flaherty L, Russo RC, Ma WE, Kuvshinoff B, Gibbs JF, Wilding GE, Yang GY, GI Cancer Symposium, 1/1/2010
• Gene expression profile (GEP) for the prediction of pathologic complete response (pCR): Preliminary data from a neoadjuvant study of capecitabine (C), oxaliplatin (OXP...
  Khushalani NI, Yang G, Tan W, Miecznikowski J, Wang D, Iyer RV, Yendamuri SS, Nwogu CE, Nava HR, Javle MM, ASCO (American Society of Clinical Oncology) Annual Meeting, 1/1/2010
• Join now to see all

Lectures

• "Proton Therapy for GI/Liver Cancers" 
  Guangzhou Medical University, Guangzhou, China - 1/1/2017
• "Proton radiotherapy for GI/liver cancers." 
  National Taiwan University, Taipei, Taiwan - 1/1/2016
• "If technology matters...What is the best way forward?" 
  Alhambra Hospital, Alhambra, CA - 1/1/2016
• "A new dawn for cancer treatment." 
  Garfield Medical Center, San Gabriel, CA - 1/1/2016
• Clinical experience with proton therapy for the treatment of the pancreas and GI tract. 
  Loma Linda University, Loma Linda, CA - 1/1/2016
• "Contemporary radiation therapy for hepatobiliary cancer." 
  University of Kansas, Kansas City, MO - 1/1/2011
• "Benefits and challenges of radiation therapy in gastric cancer." 
  Seoul, Korea - 1/1/2011
• "Esophageal Cancer-A Tough Pill to Swallow" 
  Case Western University, Cleveland, OH - 1/1/2010
• "Management of esophageal and gastric cancers." 
  Philadelphia, PA - 1/1/2009
• "Principles of modern radiation techniques for esophageal and gastroesophageal cancers." 
  Arlington, VA - 1/1/2008
• "US radiation oncology residency programs." 
  Vienna, Austria - 1/1/2004
• "Development of a new HSP-110/Her-2/neu vaccine trial for breast and ovarian cancer." 
  Buffalo, NY - 1/1/2004
• "Radiation oncology training in US" 
  Taipei, Taiwan - 1/1/2004
• Join now to see all

Other

• Bonus: for anal cancer patients,"dose-painted" IMRT = better quality of life. 
  Yang G, Physicians Practice
  1/1/2010
• "On residency applications, some fudge the details." 
  Yang G, Interview - Reuters Health
  1/1/2010
• "Phase III trial of adjuvant capecitabine/cisplatin vs capecitabine/cisplatin/RT in resected gastric cancer with D2 nodal dissection (ARTIST trial): safety analysis." 
  Yang G, HemOnc Today, ASTRO/ASCO GI Cancer Symposium
  San Francisco - 1/1/2009
• "Final safety findings from a randomized phase III trial of preoperative FU-based chemoradiation +/- weekly oxaliplatin as neoadjuvant therapy for patients with locall... 
  Yang G, HemOnc Today, ASTRO/ASCO GI Cancer Symposium
  San Francisco - 1/1/2009
• "Abdominal radiation may affect kidneys." 
  Yang G, Renal and Urology News, ASTRO (American Society for Radiation Oncology) Annual Meeting
  Boston - 1/1/2008
• "A Phase II study of cetuximab (C225) combination with chemoradiation in patients with stage IIIA/B non-small cell lung cancer: A report of the 2 year and median survi... 
  Yang G, HemOnc Today, ASTRO/ASCO Thoracic Cancer Symposium
  Chicago - 1/1/2008
• "Proton therapy with concurrent chemotherapy can reduce toxicity and allow higher radiation doses in advanced non-small cell lung cancer." 
  Yang G, HemOnc Today, ASTRO/ASCO Thoracic Cancer Symposium
  Chicago - 1/1/2008
• "Analysis of V20 and radiation pneumonitis on SWOG 0023: A phase III trial of concurrent chemoradiation and docetaxel consolidation followed by gefitinib or placebo in... 
  Yang G, HemOnc Today, ASTRO/ASCO Thoracic Cancer Symposium
  Chicago - 1/1/2008
• Join now to see all